Sofinnova MD Start IV is a Paris-based venture capital fund managed by Sofinnova Partners. €82m reported at final close (source published September 2026).
Medtech company creation: launch six to eight companies across Europe and the US over five years; support from inception through key clinical and operational milestones with capital and hands-on operational support.
Amounts come from the linked public source. A first close is not the final fund size, and a reported close does not confirm that the fund is investing now. Headquarters describe where the manager is based, not where it invests.